Professor Alan Trounson
Alan Trounson was responsible for many of the developments that made human in vitro fertilization a clinical success for treating female, male, idiopathic infertility, and preimplantation genetic diagnosis. He cofounded the Institute for Reproduction & Development, Monash University. He led the team that independently discovered human embryonic stem cells and founded the Australian Stem Cell […]
Professor Robert Shepherd
Robert Shepherd has demonstrated a sustained contribution and leadership in medical bionics over a 35 year period. He is highly regarded internationally for his research excellence in hearing, cochlear implants, retinal prostheses and medical bionics in general. He has made significant contributions to health science via his administrative roles as Director of the Bionics Institute […]
Professor John Seymour
Professor John Seymour is a clinical haematologist and Co-Director of the Division of Cancer Medicine, Peter MacCallum Centre. While maintaining ongoing direct care of patients with leukemia and lymphoma he has also consistently pursued a highly productive and internationally recognised program of clinical and translational research, both personally and has nurtured a broader program within […]
Professor Johannes (John) Prins
Professor Prins is a Key Opinion Leader in Diabetes and Endocrinology and a Clinician-Scientist with an international reputation. He has demonstrated sustained excellence in research, teaching/supervision and clinical care. In parallel, he holds leadership positions in both the health care and academic sectors, including as a Director of Metro South Hospital and health Service,with a […]
Professor Steven Petrou
Professor Petrou is a neuroscientist focussed on understanding disease mechanisms in genetic epilepsy. He has made seminal contributions to our understanding of the mechanisms underlying the pathology of genetic epilepsy. His pioneering disease models have identified the pathological changes that precede epilepsy, showing that early treatment is critical for controlling seizures and the attendant quality […]
Professor Michael Parker
Professor Parker’s international reputation in protein crystallography reflects his astonishing output of more than 100 important protein structures. His pioneering studies of membrane-associated proteins are particularly significant, since such proteins are among the most challenging targets for protein crystallography and also important drug targets. The impact of his work has been amplified greatly through the […]
Professor Terence Nolan
Professor Terry Nolan AO is an eminent public health researcher of international standing. His research has been principally in immunisation and clinical trials of new vaccines. He has over 220 publications including 205 in refereed journals and over $40m in grant funding. His research has made pivotal contributions enabling licensure of several vaccines now used […]
Professor Nicos Nicola
Prof Nick Nicola has made profound and enduring discoveries in the field of the molecular regulation of white blood cells. His early work showed that there were four different hormone-like regulators (colony-stimulating factors, CSFs) of white blood cell production and function, and he led the purification of granulocyte CSF (G-CSF), a protein that is now […]
Professor Brendan Murphy
Professor Murphy has had more than 30 years of leadership roles in the Australian Public Health system, with two distinct career phases. His initial contribution was as a clinician researcher, during which he directed a busy renal unit, lead his own research group which, inter alia, identified and characterised novel human plasma complement inhibitors, was […]
Professor Hugh McDermott
Prof McDermott has devised, developed, and evaluated numerous commercially successful innovations particularly for cochlear implants and hearing aids. Millions of adults and children with hearing impairment around the world benefit directly from his research through improved sound perception. These and other inventions are disclosed in a number of patents and patent applications. In recognition of […]
Professor Grant McArthur
Professor Grant McArthur is one of Australia’s leading clinician researchers in oncology. He has made seminal contributions to the field of therapeutic targeting on oncogenic protein kinases leading successful translation of research to target 4 different protein kinases that have established new standards of care for cancer patients globally. His work on targeting the BRAF […]
Professor Melissa Little
Professor Melissa Little is an internationally acclaimed biomedical research scientist whose work on kidney development and regenerative medicine has led to the development of protocols for growing mini-kidneys from patient-derived cell lines. This research is likely to change the way we diagnose and treat kidney disease. She has also played a major leadership role in […]
Professor Kate Leslie
Professor Kate Leslie has demonstrated distinguished professional achievement in research, education and governance in anaesthesia and the wider specialist medical community. She is recognised by her peers for her research in the areas of awareness during anaesthesia and large perioperative trials. She is also recognised for her leadership as a former president of the Australian […]
Professor Ricky Johnstone
Professor Ricky Johnstone is a recognised leader in the area of cancer epigenetics and therapeutics. He has developed sophisticated pre-clinical models to elucidate the mechanisms of action of small molecule histone deacetylase inhibitors (HDACi) and mechanisms of intrinsic and acquired tumor cell resistance to HDACi. Professor Johnstone has developed, tested and validated rational combinations of small […]
Professor Rodney Hicks
Professor Hicks has made major contributions to the care of patients with cancer through his pioneering work with positron emission tomography (PET), which has now become a routine imaging test for selecting and monitoring cancer therapies. By applying this technology in translational research he has helped develop new cancer therapies, especially targeted drugs for malignancies […]
Professor David Crawford
For over 30 years David Crawford has conducted innovative research focused on improving population health behaviours, with a focus on nutrition, physical activity and obesity. He and his team have conducted a number of intervention trials to improve health behaviours and prevent obesity, with some of these currently being rolled out as part of Victoria’s […]
Professor Peter Choong
Professor Peter Choong is an internationally recognised orthopaedic surgeon and leader in musculoskeletal research who is engaged in clinical and basic science research that covers the fields of musculoskeletal tumours, joint replacement and advanced limb reconstruction. Peter is widely published with over 260 peer-reviewed articles (H score 37) in these areas and is a recipient […]
Professor Henry Burger
Henry Burger is a clinician-scientist who has made major contributions to general and reproductive endocrinology. He was a co-leader of the group which successfully isolated inhibin. He showed that it had an important clinical role in the diagnosis and monitoring of ovarian malignancy. He defined the role of inhibin in the endocrinology of the menopausal […]
Professor Rachelle Buchbinder
Rachelle Buchbinder is a rheumatologist and clinical epidemiologist who combines clinical practice with research in a wide range of multidisciplinary projects relating to arthritis and musculoskeletal conditions. She has made seminal and original contributions to the field, with a strong emphasis on answering clinically important questions to improve patient care and outcomes. She has published […]
Professor Michael Berk
Michael Berk’s primary career focus is a novel therapy discovery program. His earlier work repurposed existing medications for novel indications, but more recently he has been developing therapies targeting novel mechanisms of action. The significance of this can be seen in the broader context. Not only are these entirely new therapies for psychiatric disorders, but […]